KEGG   PATHWAY: anu04936
Entry
anu04936                    Pathway                                
Name
Alcoholic liver disease - Arvicanthis niloticus (African grass rat)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
anu04936  Alcoholic liver disease
anu04936

Organism
Arvicanthis niloticus (African grass rat) [GN:anu]
Gene
117708952  C1qa; complement C1q subcomponent subunit A [KO:K03986]
117708169  C1qb; complement C1q subcomponent subunit B [KO:K03987]
117708170  C1qc; complement C1q subcomponent subunit C [KO:K03988]
117724307  C2; complement C2 isoform X1 [KO:K01332] [EC:3.4.21.43]
117724465  C4a; complement C4-A [KO:K03989]
117705843  C3; complement C3 [KO:K03990]
117715335  C3ar1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
117703602  C5; complement C5 [KO:K03994]
117700540  C5ar1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
117703516  Lbp; lipopolysaccharide-binding protein [KO:K05399]
117719855  Cd14; monocyte differentiation antigen CD14 [KO:K04391]
117698776  Ly96; lymphocyte antigen 96 [KO:K05400]
117709586  Tlr4; toll-like receptor 4 isoform X1 [KO:K10160]
117699498  Tirap; toll/interleukin-1 receptor domain-containing adapter protein [KO:K05403]
117693388  Myd88; myeloid differentiation primary response protein MyD88 [KO:K04729]
117718426  Irak4; interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
117694459  Irak1; interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
117703656  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
117719404  Tab1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
117700141  Tab2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
117698575  Map3k7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
117701914  inhibitor of nuclear factor kappa-B kinase subunit alpha-like [KO:K04467] [EC:2.7.11.10]
117712831  Chuk; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
117721547  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
117695513  Ikbkg; NF-kappa-B essential modulator isoform X1 [KO:K07210]
117717335  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
117722582  Rela; transcription factor p65 [KO:K04735]
117707042  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
117724681  Tnf; tumor necrosis factor isoform X1 [KO:K03156]
117704054  Il1b; interleukin-1 beta isoform X1 [KO:K04519]
117720807  Il6; interleukin-6 [KO:K05405]
117707571  Il12a; interleukin-12 subunit alpha [KO:K05406]
117711474  Il12b; interleukin-12 subunit beta [KO:K05425]
117704938  Ticam1; TIR domain-containing adapter molecule 1 [KO:K05842]
117697234  Traf3; TNF receptor-associated factor 3 [KO:K03174]
117716315  Ikbke; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
117696401  Tbk1; serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
117708685  Irf3; interferon regulatory factor 3 isoform X1 [KO:K05411]
117708733  interferon alpha-12-like [KO:K05414]
117709002  interferon alpha-12-like [KO:K05414]
117709023  interferon alpha-9 [KO:K05414]
117709053  interferon alpha-1-like [KO:K05414]
117709056  interferon alpha-1-like isoform X1 [KO:K05414]
117709071  interferon alpha-7-like [KO:K05414]
117709072  interferon alpha-12-like [KO:K05414]
117709075  interferon alpha-12-like [KO:K05414]
117709078  interferon alpha-12-like [KO:K05414]
117709079  interferon alpha-1 [KO:K05414]
117709081  interferon alpha-12-like [KO:K05414]
117709083  interferon alpha-12-like [KO:K05414]
117709084  interferon alpha-7 [KO:K05414]
117709085  interferon alpha-12-like [KO:K05414]
117709086  interferon alpha-7-like [KO:K05414]
117709102  interferon alpha-1-like [KO:K05414]
117709633  Ifnb1; interferon beta [KO:K05415]
117722669  Il17a; interleukin-17A [KO:K05489]
117715585  Il17ra; interleukin-17 receptor A isoform X1 [KO:K05164]
117715201  Il17rc; interleukin-17 receptor C isoform X1 [KO:K05166]
117712876  growth-regulated alpha protein isoform X1 [KO:K05505]
117712987  C-X-C motif chemokine 2 [KO:K05505]
117713027  C-X-C motif chemokine 3 [KO:K05505]
117716367  Faslg; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389]
117700780  Fas; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
117710030  Fadd; FAS-associated death domain protein [KO:K02373]
117714946  Tnfrsf1a; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
117723297  Tradd; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1 [KO:K03171]
117704983  Casp8; caspase-8 [KO:K04398] [EC:3.4.22.61]
117721984  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
117713706  Ripk1; receptor-interacting serine/threonine-protein kinase 1 isoform X1 [KO:K02861] [EC:2.7.11.1]
117694849  Tab3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 [KO:K12793]
117711604  Srebf1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
117710072  Fasn; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
117709906  Acaca; acetyl-CoA carboxylase 1 isoform X1 [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
117696595  acyl-CoA desaturase 4 [KO:K00507] [EC:1.14.19.1]
117705777  acyl-CoA desaturase 2 [KO:K00507] [EC:1.14.19.1]
117716910  acyl-CoA desaturase 3 [KO:K00507] [EC:1.14.19.1]
117702269  acyl-CoA desaturase 2-like [KO:K00507] [EC:1.14.19.1]
117702270  acyl-CoA desaturase 4-like [KO:K00507] [EC:1.14.19.1]
117710114  acyl-CoA desaturase 1-like [KO:K00507] [EC:1.14.19.1]
117716803  Lpin1; phosphatidate phosphatase LPIN1 isoform X1 [KO:K15728] [EC:3.1.3.4]
117693195  Lpin2; phosphatidate phosphatase LPIN2 isoform X1 [KO:K15728] [EC:3.1.3.4]
117703561  Lpin3; phosphatidate phosphatase LPIN3 [KO:K15728] [EC:3.1.3.4]
117724644  Sirt1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
117717794  Tra2b; transformer-2 protein homolog beta isoform X1 [KO:K12897]
117720537  Tra2a; transformer-2 protein homolog alpha isoform X1 [KO:K12897]
117717892  Adipoq; adiponectin [KO:K07296]
117714913  Adipor2; adiponectin receptor protein 2 [KO:K07297]
117716091  Adipor1; adiponectin receptor protein 1 [KO:K07297]
117697635  Camkk2; calcium/calmodulin-dependent protein kinase kinase 2 isoform X1 [KO:K07359] [EC:2.7.11.17]
117723868  Prkaa1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
117708512  Prkaa2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
117698037  Prkab1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
117707094  Prkab2; 5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199]
117705444  Prkag3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
117719091  Prkag1; 5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
117720702  Prkag2; 5'-AMP-activated protein kinase subunit gamma-2 [KO:K07200]
117706979  Foxo1; forkhead box protein O1 [KO:K07201]
117724341  Foxo3; forkhead box protein O3 [KO:K09408]
117712664  Ppargc1a; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1 [KO:K07202]
117718753  Ppara; peroxisome proliferator-activated receptor alpha [KO:K07294]
117704625  Cpt1a; carnitine O-palmitoyltransferase 1, liver isoform isoform X1 [KO:K08765] [EC:2.3.1.21]
117711753  Acadvl; very long-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K09479] [EC:1.3.8.9]
117707242  Acadm; medium-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K00249] [EC:1.3.8.7]
117718004  LOW QUALITY PROTEIN: peroxisomal acyl-coenzyme A oxidase 1-like [KO:K00232] [EC:1.3.3.6]
117710130  Acox1; peroxisomal acyl-coenzyme A oxidase 1 isoform X1 [KO:K00232] [EC:1.3.3.6]
117712857  Acox3; peroxisomal acyl-coenzyme A oxidase 3 [KO:K00232] [EC:1.3.3.6]
117715626  Fabp1; fatty acid-binding protein, liver [KO:K08750]
117706919  Adh7; all-trans-retinol dehydrogenase [NAD(+)] ADH7 [KO:K13951] [EC:1.1.1.1]
117707710  alcohol dehydrogenase 1 [KO:K13951] [EC:1.1.1.1]
117707173  all-trans-retinol dehydrogenase [NAD(+)] ADH4 [KO:K13980] [EC:1.1.1.1]
117707293  alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
117707512  alcohol dehydrogenase 6 [KO:K13952] [EC:1.1.1.1]
117697986  Aldh2; aldehyde dehydrogenase, mitochondrial [KO:K00128] [EC:1.2.1.3]
117708829  Aldh1b1; aldehyde dehydrogenase X, mitochondrial [KO:K00128] [EC:1.2.1.3]
117710937  Aldh3a2; aldehyde dehydrogenase family 3 member A2 isoform X1 [KO:K00128] [EC:1.2.1.3]
117719754  Aldh7a1; alpha-aminoadipic semialdehyde dehydrogenase isoform X1 [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
117716148  Aldh9a1; 4-trimethylaminobutyraldehyde dehydrogenase [KO:K00149] [EC:1.2.1.47 1.2.1.3]
117715822  cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
117698256  Acacb; acetyl-CoA carboxylase 2 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
117723417  Mlycd; malonyl-CoA decarboxylase, mitochondrial [KO:K01578] [EC:4.1.1.9]
117718598  Cpt1b; carnitine O-palmitoyltransferase 1, muscle isoform [KO:K19523] [EC:2.3.1.21]
117719424  Cpt1c; carnitine O-palmitoyltransferase 1, brain isoform isoform X1 [KO:K19524] [EC:2.3.1.21]
117720990  Nox4; NADPH oxidase 4 isoform X1 [KO:K21423] [EC:1.6.3.-]
117697536  Akt1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117706636  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
117721481  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
117718295  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
117693212  Ctnnb1; catenin beta-1 [KO:K02105]
117710774  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
117715247  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
117718257  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
117706912  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
117711496  Ccnd1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
117701010  Map3k5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
117710639  Map2k4; dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
117697775  Map2k7; dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
117705037  Mapk8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
117709966  Mapk9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
117710465  Map2k3; dual specificity mitogen-activated protein kinase kinase 3 isoform X1 [KO:K04432] [EC:2.7.12.2]
117710811  Map2k6; dual specificity mitogen-activated protein kinase kinase 6 isoform X1 [KO:K04433] [EC:2.7.12.2]
117724304  Mapk14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
117724423  Mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
117718601  Mapk12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
117718602  Mapk11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
117711275  Map3k14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:E9 (2017)
DOI:10.3390/biom7010009
Reference
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
anu00061  Fatty acid biosynthesis
anu00071  Fatty acid degradation
anu01040  Biosynthesis of unsaturated fatty acids
anu03040  Spliceosome
anu04010  MAPK signaling pathway
anu04064  NF-kappa B signaling pathway
anu04152  AMPK signaling pathway
anu04210  Apoptosis
anu04310  Wnt signaling pathway
anu04610  Complement and coagulation cascades
anu04620  Toll-like receptor signaling pathway
anu04657  IL-17 signaling pathway
anu04668  TNF signaling pathway
anu04920  Adipocytokine signaling pathway
anu05034  Alcoholism
anu05225  Hepatocellular carcinoma
KO pathway
ko04936   
LinkDB

DBGET integrated database retrieval system